VBI Vaccines New (VBIV) Stock Price, News & Analysis
Company Description
VBI Vaccines New (NASDAQ: VBIV) is classified in the biological product (except diagnostic) manufacturing industry within the Pharmaceutical Preparations sector and carries a market capitalization of $1.9M, ranking #7,225 among all listed U.S. companies by market cap.
VBIV has declined 98.6% over the past year. Shares last traded at $0.6300.
This page collects what Stock Titan holds for VBIV, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
VBI Vaccines New (VBIV) stock last closed at $0.6300. Over the past 12 months, the stock has lost 98.6%. At a market capitalization of $1.9M, VBIV is classified as a micro-cap stock.
VBIV Rankings
Latest News
VBI Vaccines New has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include clinical trial, earnings, offering. View all VBIV news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
VBIV Company Profile & Sector Positioning
VBI Vaccines New (VBIV) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.